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Abstract
Background: We hypothesize that the population with borderline personality shows different autonomic response to
methadone compared to individuals with other personalities. This study applies heart rate variability (HRV) measurements
and the Tridimensional Personality Questionnaire (TPQ) to examine this hypothesis.
Methodology/Principal Findings: Forty-four male patients with heroin dependence were recruited from a methadone
maintenance treatment program. Eight personality patterns were classified according to the TPQ norm used in Taiwan. The
borderline pattern (BP, composed of high novelty seeking, high harm avoidance and low reward dependence) and the other
personality patterns (OP) were separated into two groups. We compared the HRV profiles between the BP and OP groups.
Correlation and regression analysis were performed to clarify relationship between HRV differences and the borderline index
(BI, a new concept defined by us, which is calculated as novelty seeking + harm avoidance – reward dependence). The HRV
targets investigated included low frequency (LF) power, high frequency (HF) power, total power (TP), normalized LF (LF%),
and LF/HF. No baseline HRV parameters showed any inter-group difference. The BP group had a significantly lower DHF and
a higher DLF/HF than the OP group. The personality dimension, reward dependence, showed a negative correlation with
DLF/HF and DLF%. BI was negatively correlated with DHF and positively correlated with DLF/HF and DLF%.
Conclusions/Significance: Borderline personality individuals show increased sympathetic activity and decreased
parasympathetic activity compared to other personalities after taking methadone. The results support the hypothesis
that there is an interaction between borderline personality and autonomic modulation.
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Introduction
Heroin dependence is a complex psychiatric disorder that
causes worldwide social and economic problems [1]. It has a high
relapsing rate and therefore harm reduction becomes an
important treatment option [2]. Methadone is a widely used
agent for maintenance therapy and has been proved to reduce
illicit opioid use and criminality [3]. Many factors affect the
outcome of heroin abusers who undertake methadone mainte-
nance therapy (MMT) [4]. Personality is a frequently mentioned
one [5,6]. Research has revealed that the personality features of
patients with heroin dependence involve anxiety, impulsiveness,
and social detachment [7]. Many of them fulfill the criteria for
borderline personality disorder (BPD) as defined in Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
[5,8]. The clinical features of BPD include fear of abandonment,
explosive and self-injurious behaviors, and emotional dysregula-
tion [9]. The BPD population group shows a low retention rate
and high illicit substance exposure when undergoing MMT
[5,10,11]. However, these studies have focused on psychological
explanations for the poor outcome of MMT and the biological
mechanism of substance use behavior among BPD individuals
remains a mystery.
Disturbance of emotional regulation is a core feature of BPD
[12,13]. Polyvagal theory, constructed by Porges, provides
a connection between autonomic functioning and emotional
dysregulation [14,15,16]. The theory distinguishes between two
branches of vagus nerve. The older branch, originating from the
dorsal motor nucleus, is associated with primitive threat responses,
such as freezing. The newer branch, connected to the nucleus
ambiguous, is responsible for the modulation of social affiliation
behaviors and is only found in mammals. A threatening situation
causes inhibitory signals from the newer vagal branch to decrease
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response. The phenomenon is called vagal withdrawal. An
abnormal pattern of vagal withdrawal may explain the severe
emotional disturbance in BPD individuals [17]. Based on this
theory, Weinberg et al. found BPD subjects to have increased
sympathetic activity and decreased parasympathetic activity
compared to controls when involved with a social stressor task
[18]. We wonder if a similar response may also exist when facing
a physiological stimulus, such as treatment with methadone or
other substances. Such a concept could provide new insights into
the irregular compliance found among BPD individuals.
Heart rate variability (HRV) has been broadly used to measure
autonomic nervous system (ANS) functioning [19,20]. Frequency
domain analysis of HRV differentiates between high frequency
(HF) power, low frequency (LF) power, and very-low frequen-
cy (VLF) power [21]. HF is believed to be an index of vagal
modulation, whereas normalized LF and the LF/HF ratio reflect
sympathetic function [20,21]. Our previous study discloses that
opiates have influence on HRV. HF in heroin abusers is lower
than that in healthy population. It implies that long-term exposure
of opiates may reduce vagal modulation. On the other hand,
heroin abusers show increased HF after taking methadone, which
might originate from the relief of opiate withdrawal symptoms
[22]. Researches exploring personality dimensions and HRV have
revealed that the anxiety trait is related to HF [23,24,25]. Among
tools evaluating personality dimensions, the Tridimensional
Personality Questionnaire (TPQ) is frequently used in studies of
BPD [26,27,28]. Borderline personality is related to a pattern of
high novelty seeking (NS), high harm avoidance (HA), and low
reward dependence (RD) [29,30]. TPQ allows researchers to
analyze borderline personality from a measurable and quantitative
viewpoint distinct from DSM-IV. We consider that combining
TPQ and HRV should give further insights into borderline
personality and the biological response to methadone. In addition,
since features of borderline personality can be understood in terms
of its composition, namely NS, HA and RD, we propose that
a combination of the three scores is able to reflect the degree of
borderline personality. In the presented study, we define
borderline pattern according to TPQ distribution rather than
criteria of DSM-IV. It is because that some subjects revealing
borderline personality ‘‘trait’’ do not necessarily fulfill definition of
borderline personality ‘‘disorder’’. However, the trait may still
show specific presentations in ANS.
There are two major purposes explored in the presented study.
One is to examine if the borderline pattern and other personality
patterns have different ANS responses to methadone. The other is
to clarify if the ANS response can be predicted by a quantitative
value of personality. The two goals are based on following
hypotheses. Firstly, we assume that methadone will have a less
vagal elevating or less sympathetic reducing effect in the
borderline group than in the other personality groups. Secondly,
we hypothesize that a quantitative index that is composed of high
NS, high HA and low RD is relatable to measurable ANS
functions.
Methods and Materials
Participants and Procedures
We performed this study in Department of Psychiatry, National
Taiwan University Hospital (NTUH), Yun-Lin Branch, in
Taiwan. The Institutional Review Board of NTUH approved
the study program. In order to investigate the personality and
HRV among heroin abuser, we recruited adults from the MMT
program at the hospital. The participants were all male. This was
for two reasons. Firstly, most patients in our MMT program are
male. Secondly, HRV is affected by the menstruation cycle, which
is a factor that is hard to control for [31]. The participants’ ages
ranged from 25 to 55 years old, which was chosen so the
information gathered was that of a formed and stable personality.
Patients with mental retardation, current psychotic disorder,
diabetes mellitus, hypertension, and cardiovascular diseases, were
excluded. After completing the informed consent, a subject spent
1.5 hour answering the questionnaires and receiving two episodes
of HRV measurement. The first HRV measurement was carried
out before the individual took their regular methadone dose and
the second measurement was taken after drinking the methadone.
The interval between the two measurements was 60 minutes. All
data on each subject was gathered in a single morning (9am–
12am) in order to avoid any influence from the individual’s
circadian rhythm. In demographic data section, the various factors
known to influence HRV, such as age, smoking, baseline blood
pressure, body mass index (BMI), and exercise level, were
recorded.
Measurements
Four validated questionnaires were used in the presented study.
The Tridimensional Personality Questionnaire (TPQ) was chosen
to evaluate personality traits, which is our major analysis target.
Beck Depression Inventory (BDI), the Subjective Opiate With-
drawal Scale (SOWS) and the Opiate Treatment Index (OTI)
were also administered in order to clarify the influence of
psychological state and substance use behavior on HRV.
TPQ is a self-administered questionnaire with 100 true-false
questions [30]. It is designed to measure biological component of
personality. The Chinese version used in our study was developed
by Chen et al [32]. There are three major dimensions in TPQ and
these are novelty seeking (NS), harm avoidance (HA), and reward
dependence (RD). NS consists of NS1 (exploratory excitability),
NS2 (impulsivity), NS3 (extravagance) and NS4 (disorderliness).
HA consists of HA1 (anticipatory worry), HA2 (fear of un-
certainty), HA3 (shyness with strangers) and HA4 (fatigability and
asthenia). RD consists of RD1 (sentimentality), RD3 (attachment)
and RD4 (dependence). RD2 (persistence) has been proved to be
an independent dimension relative to other RD concepts and is
not collected into the total RD score. According to the normative
data for TPQ in Taiwan, we divided our sample to eight
personality patterns (for example, the norm of NS/HA/RD in
Taiwan is 13.2/13.8/13.5, a profile with a NS/HA/RD of 18/
17/10 is coded as ++-) [32]. Cloninger’s temperament cube theory
assumes that each pattern is associated with a personality category
[30,33]. In the presented study, the borderline pattern (BP) and
other patterns (OP) were separated into two groups in order to
examine our hypothesis. In addition, we believe that some
borderline features, such as affective instability and impulsive
behavior may be explained by combining the three major
dimensions. To quantitatively calculate the borderline features
into a single value, we develop the concept of a ‘‘borderline index’’
(BI). BI is calculated from NS total + HA total – RD total = BI
score, because high NS, high HA, low RD is the main feature of
borderline personality in Cloninger’s temperament cube theory
[30].The dimensional patterns have been found to be correlated
with scores of categorical assessing tools, such as the Personality
Disorder Questionnaire Revised [33].
BDI is a self-report inventory with 21 multiple choice questions
and measures both the cognitive and vegetative symptoms of
depression [34]. SOWS is a self-rating scale the aim of which is to
measure the severity of opioid withdrawal syndrome [35].
It contains 16 symptoms, which the intensity of which is rated
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substance use behaviors of patients with opioid dependence
[36,37,38]. In the presented study, we focus on the influence of the
estimated consumption amount (Q score) of various substances.
The prescribed benzodiazepine was calculated into tranquilizer Q
score. Each Q score is calculated by the formula: Q = (q1+ q2)/
(t1+ t2), where q1,q 2 are the substance amount used on the last and
the second last use occasion, t1 means the interval between the last
day and next to last day of substance exposure and t2 is the interval
between the second and third last day of substance exposure. The
current methadone dose was also recorded. This comes from the
individual’s medical records and is reliable.
Heart Rate Variability
We used a five-minute measurement of HRV in the present
study. Subjects were asked to sit in a relaxed manner but not to fall
asleep. A HRV analyzer (SS1C, Enjoy Research Inc., Taiwan) was
adopted for signal acquisition, storage and processing. An 8-bit
analog-to-digital converter with a sampling rate of 512 Hz was
used to record the signals. The digitized ECG signals were
analyzed online and simultaneously stored on a hard disk for
offline verification. The computer algorithm then identified each
QRS complex and rejected ventricular premature complex or
noise based on likelihood using a standard QRS template. We
resampled and interpolated normal and stationary R-R interval
values at a rate of 7.11 Hz to produce continuity in the time
domain. 2048 data points over 288 seconds was produced by the
interpolation and was used for the subsequent fast Fourier
transformation. After deleting the baseline shift, a Hamming
window was used to attenuate the leakage effect. Our algorithm
estimated the power spectrum density for each time segment. The
power spectrum was subsequently quantified into the standard
frequency-domain measurements, including high frequency (HF)
power (between 0.15 and 0.4 Hz), low frequency (LF) power
(between 0.04 and 0.15 Hz), very low frequency (VLF) power
(between 0.003 and 0.04 Hz), total power (TP), normalized LF
(LF%), and LF/HF.
Statistical Analysis
The demographic data, psychological state, substance use
behaviors and the TPQ profiling were compared between BP
and OP groups by independent t test. The differential effects of the
personality patterns (BP and OP) and methadone (before and after
taking methadone) were assessed by an independent t test and
a paired t test. The relationships between HRV, TPQ, and other
factors known to affect HRV were analyzed using correlation and
regression analysis.
Table 1. Demographic, psychological state and substance use behaviors compared between the borderline pattern and other
patterns.
Total(N=44)
Borderline pattern
(N=22) Other patterns (N=22)
Mean (6SD)/Number (%) Mean (6SD)/Number (%)Mean (6SD)/Number (%) F x2 p value
Demographics
Age (year) 36.98 (67.01) 36.68 (67.89) 37.27 (66.17%) 1.150 0.783
Gender (male) 44 (100.00%) 22 (100.00%) 22 (100.00%) NA NA
Marital status (married) 13 (29.55%) 8 (36.36%) 5 (22.73%) 0.983 0.322
Educational level (.9 years) 27 (61.36%) 12 (54.55%) 15 (68.18%) 0.863 0.353
Exercise level (hour/day) 0.33 (60.95) 0.18 (60.37) 0.47 (61.26) 2.258 0.413
BMI (kg/m
2) 23.38 (63.44) 23.68 (63.63) 23.08 (63.30) 0.004 0.568
SBP (mmHg) 124.09 (613.15) 122.91 (612.18) 125.33 (614.29) 0.309 0.552
DBP (mmHg) 77.14 (611.26) 77.45 (610.37) 76.81 (612.38) 0.125 0.854
Psychological state
BDI score 11.52 (611.24) 10.05 (610.32) 13.00 (612.15) 0.644 0.390
SOWS score 7.07 (65.51) 7.18 (65.57) 6.95 (65.58) 0.086 0.893
Substance use behaviors
Current methadone dose (mg/day) 38.16 (620.75) 38.50 (625.47) 37.82 (615.23) 3.149 0.915
Heroin Q score 0.62 (61.12) 0.50 (60.70) 0.74 (61.43) 1.749 0.482
Alcohol Q score 0.82 (63.43) 0.13 (60.29) 1.51 (64.80) 7.477 0.194
Cigarette Q score 17.64 (69.47) 15.91 (69.33) 19.36 (69.51) 0.229 0.231
Polysubstance Q score 18.88 (611.01) 16.73 (69.66) 21.02 (612.04) 0.095 0.200
Other opioid Q score 0.18 (60.82) 0.32 (61.13) 0.05 (60.21) 5.535 0.280
Amphetamine Q score 0.03 (60.15) 0.02 (60.05) 0.05 (60.21) 1.835 0.548
Tranquilizer Q score 0.09 (60.34) 0.13 (60.43) 0.05 (60.21) 1.742 0.452
Hallucinogen Q score 0.11 (60.75) 0.23 (61.07) 0.00 (60.00) 4.410 0.329
*p,0.05,
**p,0.001.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; BDI, Beck Depression Inventory; SOWS, Subjective Opiate Withdrawal Scale; Q score,
estimated consumption amount score.
doi:10.1371/journal.pone.0037464.t001
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Demographic, psychological state, and substance use behavior
data for all subjects, are shown in Table 1. The mean age is
36.9867.01 years old. All participants had been educated more
than 9 years. 29.55% of them were married. There were 22
subjects in the BP group and 22 in the OP group. Their
demographic data, BMI, and blood pressure, did not show any
significant difference. There is also no inter-group difference in
BDI score, SOWS score, and Q score for any recorded substance.
The average methadone dose of BP and OP are
38.50625.47 mg/day and 37.82615.23 mg/day, which are
similar to other studies performed in Taiwan [3]. No significant
inter-group difference in SOWS score and methadone dose
suggests that the status of tolerance and withdrawal were similar in
BP and OP.
Considering all subjects, the mean NS total score, mean HA
total score and mean RD total score are 15.0563.34, 16.3362.80
and 11.6662.08, respectively. Comparing BP and OP, the three
major dimensions NS, HA, RD all reveal a significant inter-group
difference. Among the subdimensions, only NS2 (impulsivity) is
significantly different between the two groups. As we expected, the
borderline index is significantly higher for the BP group compared
to the OP (Table 2).
Among LF, HF, TP, LF% and LF/HF, before taking
methadone, there was no significant inter-group difference.
Among the HRV parameters after taking methadone, only LF/
HF is significantly higher in BP compared to the OP group
(Fig. 1A). In addition, comparing the HRV profiles before and
after taking methadone by paired t test, BP and OP reveal
divergent manifestations. Methadone caused a significant eleva-
tion in LF and TP among both groups. However, with HF, only
the OP group show a significantly increase after taking methadone
(Fig. 1A). Noticeably, the methadone effect with respect to LF%
and LF/HF is an elevation among the BP group and a reduction
among the OP, although no significance difference was revealed
by paired t test. When we examine the difference in HRV profiles,
which are defined as values after methadone subtracted from the
values before methadone, there are some positive findings. DHF is
significantly lower among the BP group, while DLF/HF is higher
among the BP group (Fig. 1B).
The relationship between TPQ profile and HRV parameters
was further examined by correlation analysis. Considering the
traditional three TPQ major dimensions, RD is negatively
correlated with DLF% (r=20.368, p=0.014) and DLF/HF
(r=20.354, p=0.018), while NS and HA do not show any
significant correlation with HRV differences. The combinative
value BI reveals a more meaningful connection with HRV. DHF is
negatively correlated with BI, while DLF% and DLF/HF show
positive correlations with BI. Multiple linear regression analysis
reveals that BI is predictive of DHF, DLF%, and DLF/HF. Age,
BMI, SOWS score, and BDI score have no significant meaning
with respect to the regression model (Table 3). Figure 2 is a simple
linear regression model of BI and the relationships with DHF,
DLF%, DLF/HF.
Discussion
This is the first study to demonstrate diverging ANS reactions
after methadone consumption in borderline and other personal-
ities. In summary, there are two major findings in the presented
study. Firstly, after taking methadone, DHF and DLF/HF are
significantly different between the BP and OP groups. BP shows
a lower DHF but a higher DLF/HF, which corresponds with our
Table 2. TPQ data between borderline pattern and other pattern individuals.
Total (N=44) Borderline pattern (N=22) Other patterns (N=22)
Mean (6SD) Mean (6SD) Mean (6SD) F x2 p value
NS1 (exploratory excitability) 3.56 (61.45) 3.89 (61.35) 3.23 (61.51) 0.409 0.132
NS2 (impulsivity) 3.08 (61.40) 3.75 (61.39) 2.41 (61.06) 1.062 0.001*
NS3 (extravagance) 3.43 (61.58) 3.50 (61.47) 3.36 (61.71) 0.257 0.780
NS4 (disorderliness) 4.98 (61.58) 5.25 (61.46) 4.70 (61.68) 0.329 0.258
HA1 (anticipatory worry) 3.79 (61.47) 4.09 (61.34) 3.50 (61.56) 0.076 0.186
HA2 (fear of uncertainty) 3.64 (61.33) 3.86 (61.16) 3.41 (61.47) 0.941 0.262
HA3 (shyness with strangers) 3.27 (61.32) 3.50 (61.14) 3.05 (61.46) 0.004 0.257
HA4 (fatigability and asthenia) 5.64 (61.42) 5.77 (61.41) 5.50 (61.44) 0.036 0.530
RD1 (sentimentality) 3.91 (61.26) 3.59 (61.53) 4.23 (60.81) 4.189 0.095
RD2 (persistence) 4.77 (61.32) 4.80 (61.49) 4.75 (61.17) 0.606 0.910
RD3 (attachment) 5.93 (61.27) 5.64 (61.14) 6.23 (61.34) 0.058 0.123
RD4 (dependence) 1.82 (61.57) 1.64 (61.46) 2.00 (61.69) 1.482 0.449
NS total 15.05 (63.34) 16.39 (61.86) 13.71 (63.95) 6.944 0.007*
HA total 16.33 (62.80) 17.22 (62.25) 15.44 (63.06) 2.446 0.034*
RD total 11.66 (62.08) 10.86 (61.52) 12.45 (62.29) 3.470 0.009*
Borderline index 19.72 (65.17) 22.74 (64.08) 16.70 (64.36) 0.003 ,0.001**
*p,0.05,
**p,0.001.
RD total does not include RD2.
Borderline index = NS total + HA total – RD total.
TPQ, Tridimensional Personality Questionnaire; NS, novelty seeking; HA, harm avoidance; RD, reward dependence.
doi:10.1371/journal.pone.0037464.t002
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borderline personality, BI, is negatively correlated with DHF and
positively correlated with DLF% and DLF/HF, which supports
our second hypothesis.
The OP groups shows a significant elevation in HF and a slightly
reduction of LF% and LF/HF after drinking methadone.
However, after methadone consumption, the BP group shows
limited HF elevation together with a LF and LF/HF increase. This
implies that members of the BP group tend to have higher
sympathetic and lower parasympathetic activities after taking
methadone. Other factors known to affect HRV, such as age,
BMI, exercise level, emotional state, and substance exposure, do
Figure 1. Comparison of heart rate variability (HRV) parameters before and after taking methadone. (A) After methadone consumption,
low frequency (LF) power and total power (TP) in the borderline pattern (BP) group and in the other patterns (OP) group are both elevated, while
high frequency (HF) power only shows a significant elevation in OP group. Noticeably, the normalized LF (LF%) and LF/HF increase slightly after
taking methadone among the BP group. (B) The HF and LF/HF are significantly different between the BP and OP groups. *p,0.05 vs. OP, {p,0.05 vs.
before.
doi:10.1371/journal.pone.0037464.g001
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and the heroin Q scores for the two groups indicate that the
differences in HRV response are not due to noncompliance or
opioid withdrawal. Multiple linear regression analysis also
confirmed that personality profiles have a predictive meaning in
terms of HRV response. This strongly suggests that there is
a relationship between personality pattern and HRV response.
Our results are similar to Weinberg et al.’s study and are
compatible with the polyvagal theory [17,18]. Furthermore, BPD
individuals have been found to have a higher risk developing
stroke and ischemic heart disease, which can also be understood in
terms of sympathovagal imbalance [39].
The clinical features of BPD can be explained from a ANS
perspective. When suffering an unpleasant or stressful event, the
BPD population lacks self-stabilizing ability. The elevation in
sympathetic tone overwhelms their deficient vagal modulation,
which induces an intense flight-or-fight response [18]. This results
in affective instability, difficulty controlling anger, destructive
behavior, and even self-damaging. The limited increase in HF
after drinking methadone implies that central nervous system
depressants have only a partial inhibiting or relaxing effect on
members of the BPD population. The phenomenon of positive
partial reinforcement results in a trend whereby BPD patients take
more drugs to stabilize themselves, leading to addictive behaviors
[40]. The above mechanisms also generate noncooperation, a low
retention rate, and a poor prognosis for MMT among these
individuals.
Cloninger hypothesized that NS, HA and RD are related to
different brain systems. NS is associated with dopamine, while HA
is related to serotonin in dorsal raphe nucleus and gamma-amino
butyric acid; RD is bound up with norepinephrine [41,42]. The
high correlation between HRV parameters and the borderline
index, implies the complexity of the borderline personality
features. If we calculate three dimensions separately, only the
correlation between RD and DLF% and DLF/HF are significant.
Norepinephrine is the most important neurotransmitter both in
the dimension RD and sympathetic nervous system [31,42]. HA
total score, which reflects the degree of anxiety trait, did not show
significant correlation with DHF, DLF%, or DLF/HF. The
relation between HRV and monoaminergic biology in BPD
subjects warrants further investigation.
Table 3. Predictors of HRV difference after controlling for
age, BMI, exercise level, SOWS score, BDI score, current
methadone dose and substance Q scores by multiple linear
regression analysis.
gHF gLF% gLF/HF
R
2 0.147 0.324 0.441
b p valueb p value b
p
value
Age 0.004 0.983 20.088 0.590 20.029 0.854
BMI 0.078 0.674 20.108 0.522 20.089 0.595
Exercise level 20.095 20.595 0.333 0.045* 0.200 0.200
SOWS score 0.063 0.725 0.094 0.567 0.083 0.586
BDI score 0.118 0.512 20.171 0.295 20.108 0.492
Current methadone
dose
0.004 0.983 20.243 0.168 20.337 0.039*
Heroin Q score 0.040 0.833 20.246 0.157 20.233 0.174
Alcohol Q score 0.287 0.111 20.281 0.086 20.331 0.037*
Cigarette Q score 20.108 0.546 20.002 0.991 0.096 0.560
Tranquilizer Q score20.104 0.563 20.044 0.786 20.094 0.538
Borderline index 20.383 0.037* 0.465 0.007* 0.448 0.009*
*p,0.05,
**p,0.001.
HRV, heart rate variability; BMI, body mass index; SOWS, Subjective Opiate
Withdrawal Scale; BDI, Beck Depression Inventory; Q score, estimated
consumption amount score; HF, high frequency power of HRV, LF, low
frequency power of HRV, LF%, normalized low frequency power of HRV.
doi:10.1371/journal.pone.0037464.t003
Figure 2. A simple linear regression model of the borderline
index and differences in high frequency power of heart rate
variability (HF), normalized low frequency power of heart rate
variability (LF%), ratio of LF/HF (LF/HF) before and after taking
methadone. The borderline index, defined by novelty seeking score +
harm avoidance score – reward dependence score = BI score from the
Tridimensional Personality Questionnaire is used as a proposed value
for evaluating the severity of borderline features.
doi:10.1371/journal.pone.0037464.g002
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group. Although a positive correlation exists, the borderline
pattern of TPQ is not identical to the BPD defined in DSM-IV.
Personality disorders in DSM-IV are not mutually-exclusive and
as a result several types of personality disorder can be diagnosed in
one patient. This is a different approach to the TPQ pattern
classification. Therefore, whether the results of TPQ pattern can
be applied into clinical BPD needs more examinations. Further-
more, we only recruited male subjects into this study, but 75% of
patients with a BPD diagnosis are female [9]. However,
a combination of high novelty seeking and high harm avoidance
has been reported to be more frequent in male BPD patients [43].
In addition, in terms of limitations, the subjects who completed all
questionnaires and HRV measurements are likely to be the more
cooperative individuals. Therefore, our sample cannot reflect all
patients with heroin dependence. The results also need a larger
sample size to confirm.
Our study gives a reasonable connection between borderline
personality, methadone, and autonomic function. The result can
be extended to explain the emotional dysregulation and addictive
behaviors of BPD individuals. As a pilot study in this field, our
results provide a new insight into the ANS modulation of patients
with heroin dependence. Integration with BPD as defined in the
DSM-IV and an investigation of female subjects seem likely to be
the follow-up goals. A comprehensive design is needed to validate
the findings described above and to clarify the mechanisms
involved.
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